AE Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Buy
3,106
+325
+12% +$35.3K ﹤0.01% 1253
2026
Q1
$257K Buy
+2,781
New +$279K ﹤0.01% 1474
2024
Q1
Sell
-16,690
Closed -$386K 1475
2023
Q4
$386K Sell
16,690
-2,622
-14% -$68.8K ﹤0.01% 1585
2023
Q3
$572K Buy
+19,312
New +$679K ﹤0.01% 1306
2021
Q2
Sell
-1,395
Closed -$213K 1622
2021
Q1
$213K Buy
+1,395
New +$211K ﹤0.01% 1386
2020
Q1
Sell
-4,897
Closed -$383K 1179
2019
Q4
$383K Buy
4,897
+114
+2% +$8.21K 0.01% 821
2019
Q3
$305K Sell
4,783
-152
-3% -$13.4K 0.01% 778
2019
Q2
$426K Buy
+4,935
New +$377K 0.01% 629

Other funds holding GH

AE Wealth Management's GH Position: Q2 2026 in Review

AE Wealth Management increased its Guardant Health (GH) stake by 12% in Q2 2026, buying an estimated $35.3K and bringing the position to 3,106 shares worth $466K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

AE Wealth Management first reported a position in GH in Q2 2019 and has held it in 8 quarters since. The position peaked at $572K in Q3 2023. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • AE Wealth Management held 3,106 shares of Guardant Health worth $466K as of Q2 2026.
  • AE Wealth Management bought 325 Guardant Health shares in Q2 2026, an estimated $35.3K.
  • Guardant Health made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #1253 holding.
  • AE Wealth Management first reported a position in Guardant Health in Q2 2019 and has held it in 8 quarters since.
  • AE Wealth Management's Guardant Health position peaked at $572K in Q3 2023.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.